Long-term results of treatment of childhood and adolescent Hodgkin's disease in 73 patients: The experience of the departments of radiology and hematology of the University of Rome "La Sapienza"

Haematologica

Volumn 81, Issue 3, 1996, Pages 245-252

  Enrici, Riccardo Maurizi ^b   Anselmo, Anna Paola ^a   Osti, Mattia Falchetto ^a   Sbarbati, Stefano ^a   Tombolini, Vincenzo ^a   Cartoni, Claudio ^a   Mandelli, Franco ^a   Biagini, Carissimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Chemotherapy; Children; Hodgkin's disease; Long term survival; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; HEMATOLOGY; HODGKIN DISEASE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; RADIOLOGY; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; CHILD; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; MALE; RETROSPECTIVE STUDIES; ROME;

EID: 0030326428     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Smith KL, Raverra G. Comparision of the clinical course of Hodgkin's disease in children and adolescents. Med Pediatr Oncol 1976; 2:361-70.
2. Donaldson SS, Glatstein E, Rosenberg SA, et al. Pediatric Hodgkin's disease. Results of therapy. Cancer 1976; 37:2436-47.
3. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26:1063-81.
4. Carbone PP, Kaplan HS, Musshoff K, Smithers PW, Tubiana M. Report of the Committee on Hodgkin's disease staging classification. Cancer Res 1971; 31:1860-1.
5. Mandelli F, Biagini C, Baroni CD, et al. Treatment of non Hodgkin's lymphoma with "PROVECIP" (procarbazine, vinblastine, cyclophosphamide and prednisone). Haematologica 1980; 65:107-18.
6. Kaplan ES, Meier P. Non parametric estimation from incomplete observations. Am Stat Assoc J 1958; 53:457-80.
7. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and example. Br J Can 1977; 35:1-39.
8. Cleary SF, Link MP, Donaldson SS. Hodgkin's disease in the very young. Int J Radiat Oncol Biol Phys 1994; 28:77-83.
9. Vecchi V, Pileri S, Burnelli R, et al. Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients. Cancer 1993; 72:2049-57.
10. Ortin TTS, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys 1990; 19:873-80.
11. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: pulmonary, cardiac and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 1989; 16:679-85.
12. Makepeace AR, Maclennan KA, Vaughan Hudson G, et al. Hodgkin's disease in childhood: the British National lymphoma investigation experience (BNLI report No 27). Clin Radiol 1987; 38: 7-11.
13. Oberlin O, Leverger G, Pacquement H, et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. J Clin Oncol 1992; 10:1602-8.
14. Barrantes M, Gonzalez M, Jimenez R. Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy. Med Pediatr Oncol 1994; 22:398-403.
15. Maity A, Goldwein JW, Lange B, et al. Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania. J Clin Oncol 1992; 10:929-35.
16. Weiner MA, Leventhal BG, Marcus R, et al. Intensive chemotherapy and low dose radiotherapy for the treatment of advanced stage Hodgkin's disease in pediatric patients: A pediatric oncology group study. J Clin Oncol 1991; 9:1591-8.
17. Williams J, Thompson E, Smith KL. Long-term results of children and adolescents with Hodgkin's disease. Cancer 1980; 46:2123-5.
18. Schellong G, Bramswig JH, Hornig-Franz I. Treatment of children with Hodgkin's disease. Results of the German Pediatric Oncology Group. Ann Oncol 1992; 3 (Suppl 4):73-6.
19. Willman KY, Cox RS, Donaldson SS. Radiation induced height impairment in pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys 1994; 28:85-92.
20. Littman PS, D'Angio GJ. Growth consideration in the radiation therapy of children with cancer. Ann Rev Med 1979; 30: 405-15.
21. Probert JC, Parker BR, Kaplan HS. Growth retardation in children after megavoltage irradiation of the spine. Cancer 1973; 32: 634-9.
22. Hudson M, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993; 11:100-8.
23. Balwierz W, Armata J, Moryl-Bujakowska A, et al. Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987. Acta Paediatr Jpn 1991; 33:703-8.
24. Chilcote RR, Bacher RL, Hammond D. Septicemia and meningitis in children splenectomized for Hodgkin's disease. N Engl J Med 1976; 46:507-9.
25. Rosenstock GJ, D'Angio GJ, Kiesewetter WB. The incidence of complications following slanging laparotomy for Hodgkin's disease. Am J Roentgentol, Radium Ther Nuclear Med 1974; 120:531-5.
26. Heier HE. Splenectomy and serious infections. Scand J Haematol 1980; 24:5-12.
27. Tibault C, Mamazza J, Letourneau R, Poulin E. Laparoscopic splenectomy: operative technique and preliminary report. Surg Laparosc Endosc 1992; 2:248-53.
28. Tulman S, Holcomb III GW, Karamancukian HL, Reynhout J. Pediatric laparoscopic splenectomy. Ped Surg 1993; 28: 689-92.
29. Silvestri F, Russo D, Fanin R, et al. Laparoscopic splenectomy in the management of hematological diseases. Haematologica 1995; 80:47-9.
30. Bader SB, Weinstein H, Mauch P, et al. Pediatric stage IV Hodgkin's disease. Long-term survival. Cancer 1993; 72:249-55.
31. Fryer CJ, Hutchinson RJ, Krailo M, et al. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease: a report from the Childrens Cancer Study Group. J Clin Oncol 1990; 8:1971-80.
32. Jenkin D, Doyle J, Berry M, et al. Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy late results and toxicity. Med Pediatr Oncol 1990; 18:265-72.
33. Bramswig JH, Heimes U, Heiermann E, et al. The effects of cumulative doses of chemotherapy on testicular function: results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 1990; 65:1298-302.
34. Shafford EA, Kingston JE, Malpas JS, et al. Testicular function following the treatment of Hodgkin's disease in childhood. Br J Cancer 1993; 68:1199-204.
35. Green DM. Effects of treatment for childhood cancer on vital organ systems. Cancer 1993; 71(suppl. 10):3299-305.
36. LaMonte CS, Yeh SD, Straus DJ. Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin. Cancer Treat Rep 1986; 70:439-44.
37. Van der Velden JW, Van Puten WL, Guine VF, et al. Subsequent development of acute non lymphocytic leukemia in patients treated for Hodgkin's disease. Int J Cancer 1988; 42:252-5.
38. Economopoulos T, Stathakis N, Alexopoulos C, et al. Second malignancies following treatment for Hodgkin's disease: a Greek experience. Haematologica 1994; 79:273-6.
39. Mazza P, Bocchia M, Zinzani PL, et al. Hodgkin's disease: summary of twenty years' experience. Haematologica 1992; 77:487-93.
40. Yahalom J, Petrek JA, Biddinger PW, et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992; 10:1674-81.